Clinical Trials

Clinical Trials of interest to cytokine & interferon researchers huCART19-IL18 in NHL/CLL Patients ClinicalTrials.gov ID NCT04684563 Sponsor University of Pennsylvania Information provided by University of Pennsylvania (Responsible Party) Last Update Posted 2024-05-13 Low Dose IL-2 for the Treatment of Crohn’s Disease ClinicalTrials.gov ID NCT04263831 Sponsor Boston Children’s Hospital Information provided [READ MORE]

Clinical Trials of interest to cytokine & interferon researchers Non-Eosinophilic Biological Effects of IL-5 ClinicalTrials.gov ID NCT06026202 Sponsor Imperial College London Information provided by Imperial College London (Responsible Party) Last Update Posted 2023-10-30 A Study of 19-28z/IL-18 in People With Acute Lymphoblastic Leukemia (ALL) ClinicalTrials.gov ID NCT06287528 Sponsor Memorial Sloan [READ MORE]

Assessment of FOXP3 Gene Polymorphisms and Serum Interleukin 10 in Patients With ITP (FoxP3ITP) ClinicalTrials.gov ID NCT05410249 Sponsor Sohag University Information provided by Noha Saber Shafik, Sohag University (Responsible Party) Last Update Posted 2023-04-12 Targeting IL-17A for Treatment-Resistant Depression ClinicalTrials.gov ID NCT04979910 Sponsor Icahn School of Medicine at Mount Sinai [READ MORE]

Human Recombinant Interferon Gamma in the Treatment of Ventilator-acquired Pneumonia in ICU Patients (IGNORANT) ClinicalTrials.gov ID NCT05843786 Sponsor Hospices Civils de Lyon Information provided by Hospices Civils de Lyon (Responsible Party) Allogeneic Hematopoietic Cell Transplantation With Pegylated Interferon Alfa-2a for Primary and Secondary Myelofibrosis (ATIOM) ClinicalTrials.gov ID NCT05535764 Sponsor University [READ MORE]

Recombinant Interleukin-15 in Combination With Checkpoint Inhibitors Nivolumab and Ipilimumab in People With Refractory CancersClinicalTrials.gov ID NCT03388632Sponsor National Cancer Institute (NCI)Information provided by National Institutes of Health Clinical Center (CC) (National Cancer Institute (NCI)) (Responsible Party) Interleukin-34 Level in Periodontal DiseaseClinicalTrials.gov ID NCT05962567Sponsor Ain Shams UniversityInformation provided by Nada Zidan, Ain Shams University (Responsible Party) TNFalpha and Interleukin 2 [READ MORE]

Clinical Trials of interest to cytokine & interferon researchers [READ MORE]

By Marta Catalfamo Interleukin-1 Blockade in Acute Myocardial Infarction to Prevent Heart Failure (Virginia-ART4) Principal Investigators: Benjamin Van Tassell, PharmD. Virginia Commonwealth University. Richmond, Virginia, United States, 23298 Contact: Benjamin Van Tassell, PharmD. Phone: 804-828-4583 ClinicalTrials.gov Identifier: NCT05177822   Safety and Efficacy of Interferon-Gamma 1b in Patients With Candidemia Principal Investigators: [READ MORE]

By Marta Catalfamo Treatment With Dinutuximab Beta, Zoledronic Acid and Low-dose Interleukin (IL-2) in Patients With Leiomyosarcoma (DiTuSarc) ClinicalTrials.gov Identifier: NCT05080790  Contact: Daniel Pink, Dr.              033631 73527            daniel.pink@helios-gesundheit.de Contact: Melanie Prause              069 7601 4211          prause.melanie@ikf-khnw.de Sponsors and Collaborators Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest EUSA Pharma, Inc. [READ MORE]